115 related articles for article (PubMed ID: 7505567)
21. Protein kinase FA/glycogen synthase kinase-3 predominantly phosphorylates the in vivo site Thr97-Pro in brain myelin basic protein: evidence for Thr-Pro and Ser-Arg-X-X-Ser as consensus sequence motifs.
Yu JS; Yang SD
J Neurochem; 1994 Apr; 62(4):1596-603. PubMed ID: 7510785
[TBL] [Abstract][Full Text] [Related]
22. Tau is phosphorylated by GSK-3 at several sites found in Alzheimer disease and its biological activity markedly inhibited only after it is prephosphorylated by A-kinase.
Wang JZ; Wu Q; Smith A; Grundke-Iqbal I; Iqbal K
FEBS Lett; 1998 Sep; 436(1):28-34. PubMed ID: 9771888
[TBL] [Abstract][Full Text] [Related]
23. Tau protein kinase I/GSK-3 beta/kinase FA in heparin phosphorylates tau on Ser199, Thr231, Ser235, Ser262, Ser369, and Ser400 sites phosphorylated in Alzheimer disease brain.
Song JS; Yang SD
J Protein Chem; 1995 Feb; 14(2):95-105. PubMed ID: 7786411
[TBL] [Abstract][Full Text] [Related]
24. Phosphorylation of tau at both Thr 231 and Ser 262 is required for maximal inhibition of its binding to microtubules.
Sengupta A; Kabat J; Novak M; Wu Q; Grundke-Iqbal I; Iqbal K
Arch Biochem Biophys; 1998 Sep; 357(2):299-309. PubMed ID: 9735171
[TBL] [Abstract][Full Text] [Related]
25. Sequential phosphorylation of Tau by glycogen synthase kinase-3beta and protein kinase A at Thr212 and Ser214 generates the Alzheimer-specific epitope of antibody AT100 and requires a paired-helical-filament-like conformation.
Zheng-Fischhöfer Q; Biernat J; Mandelkow EM; Illenberger S; Godemann R; Mandelkow E
Eur J Biochem; 1998 Mar; 252(3):542-52. PubMed ID: 9546672
[TBL] [Abstract][Full Text] [Related]
26. Indirubins inhibit glycogen synthase kinase-3 beta and CDK5/p25, two protein kinases involved in abnormal tau phosphorylation in Alzheimer's disease. A property common to most cyclin-dependent kinase inhibitors?
Leclerc S; Garnier M; Hoessel R; Marko D; Bibb JA; Snyder GL; Greengard P; Biernat J; Wu YZ; Mandelkow EM; Eisenbrand G; Meijer L
J Biol Chem; 2001 Jan; 276(1):251-60. PubMed ID: 11013232
[TBL] [Abstract][Full Text] [Related]
27. Protein kinase FA/glycogen synthase kinase 3 alpha predominantly phosphorylates the in vivo sites of Ser502, Ser506, Ser603, and Ser666 in neurofilament.
Yang SD; Huang JJ; Huang TJ
J Neurochem; 1995 Apr; 64(4):1848-54. PubMed ID: 7891113
[TBL] [Abstract][Full Text] [Related]
28. Dephosphorylation of abnormal sites of tau factor by protein phosphatases and its implication for Alzheimer's disease.
Ono T; Yamamoto H; Tashima K; Nakashima H; Okumura E; Yamada K; Hisanaga S; Kishimoto T; Miyakawa T; Miyamoto E
Neurochem Int; 1995 Mar; 26(3):205-15. PubMed ID: 7787767
[TBL] [Abstract][Full Text] [Related]
29. [Abnormal proteins in the brain in Alzheimer's disease].
Kanemaru K; Ihara Y
Tanpakushitsu Kakusan Koso; 1991 Jan; 36(1):2-11. PubMed ID: 1900947
[No Abstract] [Full Text] [Related]
30. The kinase DYRK phosphorylates protein-synthesis initiation factor eIF2Bepsilon at Ser539 and the microtubule-associated protein tau at Thr212: potential role for DYRK as a glycogen synthase kinase 3-priming kinase.
Woods YL; Cohen P; Becker W; Jakes R; Goedert M; Wang X; Proud CG
Biochem J; 2001 May; 355(Pt 3):609-15. PubMed ID: 11311121
[TBL] [Abstract][Full Text] [Related]
31. [Direct demonstration of abnormal phosphorylation of Tau microtubular proteins in Alzheimer's disease].
Flament S; Delacourte A; Hemon B; Defossez A
C R Acad Sci III; 1989; 308(3):77-82. PubMed ID: 2493316
[TBL] [Abstract][Full Text] [Related]
32. Phosphorylation of tau by glycogen synthase kinase 3beta affects the ability of tau to promote microtubule self-assembly.
Utton MA; Vandecandelaere A; Wagner U; Reynolds CH; Gibb GM; Miller CC; Bayley PM; Anderton BH
Biochem J; 1997 May; 323 ( Pt 3)(Pt 3):741-7. PubMed ID: 9169608
[TBL] [Abstract][Full Text] [Related]
33. Glycogen synthase kinase-3 beta is a dual specificity kinase differentially regulated by tyrosine and serine/threonine phosphorylation.
Wang QM; Fiol CJ; DePaoli-Roach AA; Roach PJ
J Biol Chem; 1994 May; 269(20):14566-74. PubMed ID: 7514173
[TBL] [Abstract][Full Text] [Related]
34. Rapid Alzheimer-like phosphorylation of tau by the synergistic actions of non-proline-dependent protein kinases and GSK-3.
Singh TJ; Haque N; Grundke-Iqbal I; Iqbal K
FEBS Lett; 1995 Jan; 358(3):267-72. PubMed ID: 7531159
[TBL] [Abstract][Full Text] [Related]
35. [Abnormal proteins in the brain in Alzheimer's disease].
Nukina N; Mannen T
Tanpakushitsu Kakusan Koso; 1989 Sep; 34(12 Suppl):1725-32. PubMed ID: 2555845
[No Abstract] [Full Text] [Related]
36. Microtubule-associated protein/microtubule affinity-regulating kinase (p110mark). A novel protein kinase that regulates tau-microtubule interactions and dynamic instability by phosphorylation at the Alzheimer-specific site serine 262.
Drewes G; Trinczek B; Illenberger S; Biernat J; Schmitt-Ulms G; Meyer HE; Mandelkow EM; Mandelkow E
J Biol Chem; 1995 Mar; 270(13):7679-88. PubMed ID: 7706316
[TBL] [Abstract][Full Text] [Related]
37. In vitro analysis of tau phosphorylation sites and its biological activity.
Wang J; Wang X; Liu R; Wang Q; Grundke-Iqbal I; Iqbal K
Chin Med Sci J; 2002 Mar; 17(1):13-6. PubMed ID: 12894878
[TBL] [Abstract][Full Text] [Related]
38. cAMP-dependent protein kinase phosphorylations on tau in Alzheimer's disease.
Jicha GA; Weaver C; Lane E; Vianna C; Kress Y; Rockwood J; Davies P
J Neurosci; 1999 Sep; 19(17):7486-94. PubMed ID: 10460255
[TBL] [Abstract][Full Text] [Related]
39. Non-proline-dependent protein kinases phosphorylate several sites found in tau from Alzheimer disease brain.
Singh TJ; Zaidi T; Grundke-Iqbal I; Iqbal K
Mol Cell Biochem; 1996 Jan; 154(2):143-51. PubMed ID: 8717428
[TBL] [Abstract][Full Text] [Related]
40. Characterization of mAb AP422, a novel phosphorylation-dependent monoclonal antibody against tau protein.
Hasegawa M; Jakes R; Crowther RA; Lee VM; Ihara Y; Goedert M
FEBS Lett; 1996 Apr; 384(1):25-30. PubMed ID: 8797796
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
